1-20 of 24
Harsh Parmar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real World Outcomes of Multiple Myeloma Patients Who Underwent Apheresis for Planned Chimeric Antigen Receptor (CAR) T Cell Therapy: A Single Center Experience

Ayrton I Bangolo, Sarvarinder Kaur Gill, Behzad Amoozgar, Shraboni Dey, Ronit Slotky, David S. Siegel, Harsh Parmar, Noa Biran, David H. Vesole, Pooja Phull
Journal: Blood
Blood (2024) 144 (Supplement 1): 7097.
https://doi.org/10.1182/blood-2024-211895
Published: 2024
Journal Articles

Iopofosine I 131 in Previously Treated Patients with Waldenström Macroglobulinemia (WM): Efficacy and Safety Results from the International, Multicenter, Open-Label Phase 2 Study (CLOVER-WaM™)

Sikander Ailawadhi, Maria Gavriatopoulou, Jennifer Peterson, Ioannis Ntanasis-Stathopoulos, Ghassan El-Haddad, Ariel Grajales-Cruz, Aimaz Afrough, Moshe Y. Levy, Judith Trotman, Kimberly R. Doucette, Jorge J. Castillo, Francisco Hernandez-Ilizaliturri, Ajay K. Nooka, Shirley D'Sa, Ralph V. Boccia, Harsh Parmar, Carlos Fernández de Larrea, Guldane Cengiz Seval, Luiza Beatriz Goncalves Beber, Radhakrishnan Ramchandren, Sheeba K. Thomas, Jarrod Longcor, Andrei Shustov, Larry D Anderson, Jr.
Journal: Blood
Blood (2024) 144 (Supplement 1): 861.
https://doi.org/10.1182/blood-2024-200277
Published: 2024
Journal Articles

A Phase 2b Study of Selinexor in Combination with Pomalidomide in Patients with Pomalidomide-Refractory Multiple Myeloma

Noa Biran, David H. Vesole, Harsh Parmar, Pooja Phull, Kimberly R. Doucette, Rena Feinman, Xue Geng, Jaeil Ahn, Joshua Zenreich, Palka Anand, Kristin Ivanovski, Monique Pace, Alexandra Della Pia, Bianca DeAgresta, Lisa Biamonte, Martha Campanaro, Trina McClendon, Samanta BaboolallAracena, Adolfo Aleman, Ella Rutanen, Marie Layton, Genevieve Breeze, Aimee Chappell, Susan Kumka, David S. Siegel
Journal: Blood
Blood (2024) 144 (Supplement 1): 7070.
https://doi.org/10.1182/blood-2024-208473
Published: 2024
Journal Articles

Real World Outcomes with Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody: A Single Center Experience for Relapsed/ Refractory Multiple Myeloma (RRMM)

Sarvarinder Kaur Gill, Erika Fleming, Helen Gebre, Ayrton I Bangolo, David S. Siegel, David H. Vesole, Noa Biran, Harsh Parmar, Pooja Phull
Journal: Blood
Blood (2024) 144 (Supplement 1): 7047.
https://doi.org/10.1182/blood-2024-210350
Published: 2024
Journal Articles

A Single-Center Experience on the Safety and Efficacy of Venetoclax-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma

Eli Zolotov, Vanisha Patel, Yedidyah Weiss, Noa Biran, Pooja Phull, David H. Vesole, David S. Siegel, Harsh Parmar
Journal: Blood
Blood (2024) 144 (Supplement 1): 6959.
https://doi.org/10.1182/blood-2024-194740
Published: 2024
Journal Articles

Establishing a Distinct Cytokine Signature for Multiple Myeloma Using Bone Marrow RNA and Peripheral Blood Cell-Free RNA (cfRNA)

Maher Albitar, Hong Zhang, Sally Agersborg, Ahmad Charifa, Pooja Phull, Noa Biran, David H. Vesole, Harsh Parmar, Andrew L Pecora, Andrew Ip, Andre Goy, David S. Siegel
Journal: Blood
Blood (2024) 144 (Supplement 1): 3316.
https://doi.org/10.1182/blood-2024-203774
Published: 2024
Journal Articles

Comparative Efficacy and Safety of Ciltacabtagene Autoleucel and Idecabtagene Vicleucel in Real-World Relapsed/Refractory Multiple Myeloma: A Retrospective Intention-to-Treat Analysis

Behzad Amoozgar, Ayrton I Bangolo, David H. Vesole, David S. Siegel, Noa Biran, Pooja Phull, Michele L. Donato, Harsh Parmar
Journal: Blood
Blood (2024) 144 (Supplement 1): 2408.
https://doi.org/10.1182/blood-2024-211671
Published: 2024
Journal Articles

Clonotype-Naïve Detection of Clonality in Patients Suspected of Having Multiple Myeloma or Monoclonal Gammopathy Using Peripheral Blood Cell-Free RNA (cfRNA)

Maher Albitar, Hong Zhang, Sally Agersborg, Ahmad Charifa, Pooja Phull, Noa Biran, David H. Vesole, Harsh Parmar, Andrew L Pecora, Andrew Ip, Andre Goy, David S. Siegel
Journal: Blood
Blood (2024) 144 (Supplement 1): 1946.
https://doi.org/10.1182/blood-2024-201810
Published: 2024
Journal Articles

A Phase 2b Study of Selinexor in Combination with Carfilzomib, Daratumumab, or Pomalidomide in Patients with Multiple Myeloma Relapsing on Current Therapy

Noa Biran, David H. Vesole, Harsh Parmar, Pooja Phull, Kimberly Doucette, Rena Feinman, Joshua Zenreich, Palka Anand, Kristin Ivanovski, Monique Pace, Lisa Biamonte, Martha Campanaro, Trina McClendon, Chandani Limbad, Samanta BaboolallAracena, Adolfo Aleman, Rashmi Unawane, Elizabeth Pendergrass, Marie Layton, Genevieve Breeze, Aimee Chappell, Alexandra Della Pia, Susan Kumka, David S. Siegel
Journal: Blood
Blood (2023) 142 (Supplement 1): 6714.
https://doi.org/10.1182/blood-2023-187011
Published: 2023
Journal Articles

Sequential Administration of Selinexor and CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma

Sarvarinder Kaur Gill, Noa Biran, Pooja Phull, David H. Vesole, David S. Siegel, Harsh Parmar
Journal: Blood
Blood (2023) 142 (Supplement 1): 6930.
https://doi.org/10.1182/blood-2023-190413
Published: 2023
Journal Articles

Outcomes Analysis of Lenalidomide-Induced Rashes in Myeloma Patients

James Behrmann, Robert J Vanaria, Shannon Meledathu, Aishwarya Sridhar, Michael Povelaitis, Harsh Parmar, Andrew Ip
Journal: Blood
Blood (2023) 142 (Supplement 1): 6689.
https://doi.org/10.1182/blood-2023-184906
Published: 2023
Journal Articles

Single-Center Experience of Carfilzomib-Based Combinations for Patients with Lymphoplasmacytic Lymphoma

Harsh Parmar, Noa Biran, Pooja Phull, David H. Vesole, David S. Siegel
Journal: Blood
Blood (2023) 142 (Supplement 1): 1684.
https://doi.org/10.1182/blood-2023-190155
Published: 2023
Journal Articles

Teclistamab Demonstrates Clinical Activity in Real-World Patients Ineligible for the Pivotal Majestec-1 Trial

Beth Gordon, Lindsay Fogel, Gaurav Varma, Mateo Mejia Saldarriaga, Jaeil Ahn, Adolfo Aleman, Jessica Caro, Xiaoyi Chen, Jorge Monge, Harsh Parmar, David Kaminetzky, Tibor Moskovits, David S. Siegel, Gareth J. Morgan, Ruben Niesvizky, Noa Biran, Faith E. Davies
Journal: Blood
Blood (2023) 142 (Supplement 1): 4741.
https://doi.org/10.1182/blood-2023-181304
Published: 2023
Journal Articles

A Phase 1/2 Study of Carfilzomib, Iberdomide and Dexamethasone (KID) in Patients with Newly Diagnosed Transplant-Eligible Multiple Myeloma

Noa Biran, David H. Vesole, Harsh Parmar, Pooja Phull, Kimberly Doucette, Rena Feinman, Joshua Zenreich, Palka Anand, Kristin Ivanovski, Monique Pace, Lisa Biamonte, Martha Campanaro, Trina McClendon, Chandani Limbad, Samanta BaboolallAracena, Adolfo Aleman, Rashmi Unawane, Elizabeth Pendergrass, Marie Layton, Genevieve Breeze, Aimee Chappell, Alexandra Della Pia, Susan Kumka, David S. Siegel
Journal: Blood
Blood (2023) 142 (Supplement 1): 2022.
https://doi.org/10.1182/blood-2023-189907
Published: 2023
Journal Articles

A Real-World Comparison of Idecabtagene Vicleucel and Ciltacabtagene Autoleucel CAR-T Therapy: A Single Center Experience for Relapsed/ Refractory Multiple Myeloma

Sarvarinder Kaur Gill, Noa Biran, Pooja Phull, David H. Vesole, David S. Siegel, Harsh Parmar
Journal: Blood
Blood (2023) 142 (Supplement 1): 4717.
https://doi.org/10.1182/blood-2023-190583
Published: 2023
Journal Articles

Retrospective Review of Patients Treated with Intrathecal Rituximab for Primary and Secondary CNS Lymphoma and Leukemia

Tatyana Feldman, Alexandra Della Pia, Geeny Lee, Thomas S. Gunning, Michael Pelliccia, Tony Varughese, Harsh Parmar, Andrew Ip, Lori A. Leslie, Andre Goy, Samuel Singer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1773.
https://doi.org/10.1182/blood-2023-187164
Published: 2023
Journal Articles

Comparison of Fludarabine/Cyclophosphamide Vs Bendamustine As Lymphodepleting Regimen for CAR-T: A Safety and Efficacy Analysis in Patients with Relapsed/ Refractory Multiple Myeloma

Sarvarinder Kaur Gill, Noa Biran, Pooja Phull, Sukhdeep Kaur, Hyung C Suh, Christina Cho, Michele L. Donato, Scott D Rowley, David H. Vesole, David S. Siegel, Harsh Parmar
Journal: Blood
Blood (2023) 142 (Supplement 1): 6903.
https://doi.org/10.1182/blood-2023-190507
Published: 2023
Journal Articles

Effect of Daratumumab on Stem Cell Mobilization and Engraftment Kinetics Post Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma

Samir Oza, Ronit Slotky, Pranay Vissa, Pooja Phull, Sukhdeep Kaur, Hyung C. Suh, Michele L. Donato, Scott D. Rowley, Noa Biran, David H. Vesole, David Siegel, Harsh Parmar
Journal: Blood
Blood (2022) 140 (Supplement 1): 10441–10442.
https://doi.org/10.1182/blood-2022-171098
Published: 2022
Journal Articles

The Clinical Characteristics and Epidemiology of Extramedullary Multiple Myeloma over the Past Two Decades

Ayrton Bangolo, Pierre Fwelo, Chinmay Trivedi, Jennifer Hashem, Parul Jandir, Katamon Klaichart, Rua Abdelrahim, Ayodya R Perera, Manbir Singh, Rohini B Gurumoorthy, Apurva Tiwari, Sudha S Konakanchi, Nagihan Orhun, Adithya Polavarapu, Ritika Sharma, Ankit Sarkar, Anupama Gupta, Bob-Hallen E. Treisma, Thin Thiri Soe, Ashwin Penchala, Sheetal Penmetsa, Srikar Bathi, Padmavathi Muppalla, David Siegel, Noa Biran, Harsh Parmar, David H. Vesole, Simcha Weissman, Pooja Phull
Journal: Blood
Blood (2022) 140 (Supplement 1): 12521–12522.
https://doi.org/10.1182/blood-2022-170783
Published: 2022
Journal Articles

Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost

Ayrton Bangolo, Samir Oza, Ronit Slotky, Aimee Chappell, David Siegel, Harsh Parmar, Noa Biran, David H. Vesole, Pooja Phull
Journal: Blood
Blood (2022) 140 (Supplement 1): 10041–10042.
https://doi.org/10.1182/blood-2022-171012
Published: 2022